Results
Filtros
Study in the US confirms: Hemp-fed cow milk does not contain THC
Researchers indicate that human consumption is safe after a period of abstinence; previous German study had shown different results
Anvisa Nominees' Hearing Scheduled in Senate
Social Affairs Committee to analyze four names for leadership positions in health agencies
From Seizures to Stability: How Medicinal Cannabis Transformed Fernando's Life
With refractory epilepsy since adolescence, he found an effective treatment in the plant and legalized cultivation
Cannabis spray brings relief to those living with chronic muscle stiffness
Spanish study shows that medicinal cannabis spray can significantly reduce spasticity in patients with chronic spinal cord injury refractory to conventional therapies
See the main projects in the Senate and the Chamber of Deputies to regulate cannabis in Brazil
01/11/2024There are over 20 proposed laws to regulate the plant in the country.
CBDa: What is the "raw" compound of cannabis and why does it matter?
Understand how cannabidiolic acid acts before being heated and what benefits it offers
Taxonomic Classification of Cannabis sativa L.: from biology to cultural and medicinal relevance
Understand how science organizes cannabis, its subspecies, varieties, and the historical and therapeutic importance of the plant
Hemp in the off-season: plant potential as a cover crop
Agronomic, environmental, and economic benefits make hemp a promising alternative in sustainable management
Sergipe's Medicinal Cannabis Policy Receives Pharmaceutical Award
Pioneering initiative in Brazil is nationally recognized for its impact on healthcare assistance and already benefits 247 patients in the state
Ministry of Health and ANVISA receive Technical Note identifying 481 barriers to scientific development of cannabis in Brazil
Document developed by a group with 31 Brazilian academic and research institutions points out regulatory barriers and suggests an agile framework to strengthen the scientific and technological sector
Free distribution of medical cannabis by SUS in Criciúma expected to start in December
Bill approved unanimously in July 2025 establishes the Municipal Policy for the Supply of Cannabis-based Medicines, putting the city at the forefront of the topic in Brazil
Forum at UEM discusses the future of medical cannabis in Paraná
Free event discusses advances in legislation, public policies, and access to treatments
Univali authorized by Anvisa to perform analyses of Cannabis products
New authorization expands university's scope in Reblas and reinforces quality control of plant derivatives in the national market
Police operation in the countryside of São Paulo seizes medicines and supplies from the Santa Gaia association
Action leaves over 9 thousand patients, including children and elderly, at risk of interrupting treatments based on medical Cannabis
Jundiaí College recruits volunteers for groundbreaking study with cannabis in Alzheimer's
Jundiaí School of Medicine is recruiting volunteers for a pioneering study with THC and CBD in patients with moderate Alzheimer's, bringing hope for new care and improved quality of life
Medical Cannabis Patient Identification Card Approved in First Discussion in Sorocaba
Measure aims to ensure legal security and facilitate access to treatments prescribed with medical cannabis
Sorocaba introduces identification card for medical cannabis patients
New law aims to ensure legal security and prevent embarrassment for therapeutic plant users in the city
Regulation of cannabis in the SUS is under discussion in Pernambuco
Parliamentary Front pushes for agility in the regulation of the law that guarantees free access to cannabis-based medications in the state
Companies seek to streamline the export of Cannabis products from Colombia to Brazil
10/29/2025Increased demand and bottleneck at the National Narcotics Fund of Colombia cause delays of up to 60 days in certificate issuance and halve exports to Brazil
Santa Catarina Legislative Assembly discusses medicinal use of Cannabis in public hearing
Meeting addresses limits of state regulation and alternatives to expand access to treatments